Thermo Fisher Scientific
81 Wyman Street
Waltham
Massachusetts
02454
United States
Tel: 781-622-1000
Fax: 781-622-1207
Website: http://www.thermofisher.com/
1422 articles with Thermo Fisher Scientific
-
Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology
6/16/2021
Thermo Fisher Scientific today announced that submissions are now open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology.
-
Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021
6/14/2021
Enhanced solution delivers balance of speed and quality to accelerate and expedite DNA to Investigational New Drug in as little as 13 months.
-
Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021
6/8/2021
Thermo Fisher Scientific Inc. announced that Marc N. Casper , chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42 nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 9:40 a.m. (EDT) .
-
Thermo Fisher Scientific Launches Novel Flow Cytometer with Imaging Capability
6/7/2021
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Invitrogen Attune CytPix Flow Cytometer, an imaging-enhanced flow cytometer that combines acoustic focusing flow cytometry technology with a high-speed camera.
-
Thermo Fisher Scientific Launches Ion AmpliSeq SARS-CoV-2 Insight Research Assay for SARS-CoV-2 Surveillance
6/7/2021
Thermo Fisher Scientific today introduced the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improve SARS-CoV-2 surveillance.
-
Thermo Fisher Scientific Collaborates with the University of Sheffield to Advance Oligonucleotide Characterization and Analytical Workflows
6/7/2021
Thermo Fisher Scientific, the world leader in serving science, and the University of Sheffield, a leading institution with a global reputation for research excellence, have joined forces to develop advanced end-to-end workflows for the characterization and monitoring of complex oligonucleotide and mRNA products
-
Innovative Analytical Software for Enhanced Data Acquisition and Analysis
6/7/2021
Scientists within academia and industries including pharmaceutical, biopharmaceutical and food and beverage analysis, can now benefit from new and improved software capabilities to enhance productivity and usability.
-
The FDA has a massive backlog of site inspections due to the pandemic. To address the problem, the agency made its Resiliency Roadmap outlining its priorities.
-
Thermo Scientific iFLM Correlative System Enables Light Microscopy Inside the Aquilos 2 Cryo-FIB
5/19/2021
Integrated fluorescence light microscope combines light and electron microscopy into one system, removes complication of transferring samples between microscopes
-
Thermo Fisher Scientific Declares Quarterly Dividend - May 19, 2021
5/19/2021
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on July 15, 2021, to shareholders of record as of June 15, 2021.
-
Thermo Fisher Scientific and University of California, San Francisco to Open Cell Therapy cGMP Manufacturing and Collaboration Center
5/19/2021
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies.
-
Thermo Fisher Plans Cell Therapy Manufacturing Site in Bay Area; Pfizer Expands Irish Plant
5/19/2021
Thermo Fisher and the University of California partnered with the development and manufacturing of cell-based therapies with the construction of its 44,000 sq. ft. manufacturing facility. -
Automated Incubators and Storage Systems Increase Throughput and Sample Protection
5/14/2021
Pharma and biotech laboratories performing high-throughput screening, high-content screening and molecular cell biology can now benefit from a series of new automated incubators and storage solutions that offer a large capacity, fast access and wide temperature range, while helping eliminate contamination issues in high-throughput environments.
-
Life science jobs are booming in several regions around the U.S. One is the Pacific Northwest, specifically Oregon; another is the Philadelphia area. Here’s a look.
-
Thermo Fisher Scientific to Present at the BofA Securities 2021 Healthcare Conference on May 12, 2021
5/10/2021
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the BofA Securities 2021 Health Care Conference on Wednesday, May 12, 2021 at 8:45 a.m. (EDT).
-
Thermo Scientific E-CFEG Enables Accelerated Cryo-EM Discovery with High Resolution Data
4/30/2021
Thermo Fisher Scientific, the world leader in serving science, today launched the Thermo Scientific E-CFEG, the company's new cold field emission gun and a value-added component for the Thermo Scientific Krios Cryo-TEM.
-
Thermo Fisher Scientific Reports First Quarter 2021 Results
4/29/2021
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 3, 2021 . First Quarter 2021 Highlights First quarter revenue increased 59% to $9.91 billion . First quarter GAAP diluted earnings per share (EPS) increased 198% to $5.
-
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
4/15/2021
Further expands service offering to pharma and biotech customers - Establishes Thermo Fisher as a global leader in the attractive and high growth clinical research services industry - Adds highly complementary services for the company's fastest growing end market
-
The medical device maker has been dropping money like rain this spring, spending close to $19 billion in acquisitions over the past four months.
-
FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test
4/12/2021
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the Thermo Fisher Scientific Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit.